Netflix, Eli Lilly, Elanco Animal Health Among Stocks on CNBC's 'Final Trades'

On CNBC's "Midday Report Final Trades," Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, recommended Netflix, Inc.

The streaming service company's shares traded higher on Tuesday, extending a recent rebound as the stock works to reclaim key moving averages. Meanwhile, Bill Ackman's Pershing Square fund disclosed a 3.15 million-share stake in Netflix last week, representing 4.9% of its portfolio.

Bryn Talkington, managing partner at Requisite Capital Management, selected the Horizon Kinetics Inflation Beneficiaries ETF as her final trade.

Stephanie Link, chief investment strategist, head of investment solutions and equity portfolio manager at Hightower Advisors, said Elanco Animal Health Incorporated's fundamentals are very strong.

Supporting her pick, Elanco Animal Health reported better-than-expected second-quarter financial results on August 5 and raised its FY26 guidance above expectations. Additionally, the company issued third-quarter sales guidance that came in above expectations.

The pet health company reported adjusted earnings per share of 34 cents, beating the consensus estimate of 27 cents. Sales rose 10% year-over-year on a reported basis to $1.368 billion, beating the consensus estimate of $1.313 billion.

Joseph M. Terranova, senior managing director at Virtus Investment Partners, said Eli Lilly and Company is approaching all-time highs.

Supporting his view, Eli Lilly reported better-than-expected second-quarter financial results on August 5 and raised its FY26 sales guidance, with the midpoint above expectations.

Price Action

The Horizon Kinetics Inflation Beneficiaries ETF fell 0.3% on Tuesday.

Elanco Animal Health shares rose 0.1% to close at $23.64.

Eli Lilly shares gained 3.6% to close at $1,225.73.

Netflix shares rose 2.3% to close at $77.77.